Table 4.

Multiple regression association between PCMH saturation within CHC delivery sites and HRSA clinical performance scores

	Access to prenatal care	Low birth weight	Cervical cancer screening	Weight assessment & counseling (children)	Weight assessment & counseling (adults)	Colorectal cancer screening	Childhood immunization status	Appropriate medications for asthma	Coronary artery disease: lipid therapy	IVD: use of aspirin or another antithrombotic	Controlling high blood pressure
Proportion of designated delivery sites	1.02 (0.88–1.19)	0.96 (0.82–1.12)	1.16 (1.06–1.26)*	1.39 (1.23–1.57)*	1.20 (1.07–1.35)*	1.22 (1.10–1.36)*	1.01 (0.86–1.18)	1.18 (1.05–1.33)*	1.13 (1.02–1.24)*	1.15 (1.05–1.26)*	1.11 (1.03–1.19)*
Number of delivery sites	0.99 (0.98–1.00)	0.99 (0.99–1.00)	0.99 (0.98–0.99)	1.00 (0.99–1.01)	1.00 (1.00–1.01)	0.99 (0.98–1.00)	0.99 (0.98–1.00)	0.99 (0.98–1.00)	0.99 (0.98–0.99)*	1.00 (0.99–1.00)	0.99 (0.99–1.00)
% child case mix	1.19 (0.76–1.86)	1.49 (0.94–2.36)	1.25 (0.95–1.63)	2.16 (1.50–3.11)*	1.32 (0.93–1.87)	1.12 (0.81–1.56)	1.81 (1.14–2.87)*	1.03 (0.73–1.47)	0.66 (0.48–0.89)*	1.20 (0.91–1.59)	0.91 (0.74–1.13)
Urban	1.06 (0.96–1.18)	1.11 (0.99–1.23)	1.04 (0.97–1.10)	0.94 (0.87–1.03)	0.95 (0.87–1.03)	1.01 (0.93–1.09)	1.14 (1.03–1.27)*	1.04 (0.96–1.12)	1.03 (0.96–1.10)	1.02 (0.96–1.09)	0.98 (0.93–1.03)
Medicaid/CHIP	1.24 (0.88–1.75)	1.01 (0.69–1.47)	1.33 (1.08–1.65)	1.29 (0.96–1.73)	1.08 (0.82–1.42)	0.67 (0.52–0.86)*	1.05 (0.72–1.53)	0.97 (0.74–1.28)	0.89 (0.70–1.12)	0.72 (0.58–0.89)*	0.90 (0.76–1.06)
No insurance	0.77 (0.54–1.11)	1.00 (0.69–1.46)	1.23 (0.99–1.52)	1.26 (0.94–1.69)	1.28 (0.98–1.68)	0.67 (0.52–0.86)	1.18 (0.81–1.72)	0.88 (0.67–1.16)	0.98 (0.79–1.23)	0.68 (0.55–0.84)*	0.63 (0.53–0.74)*
Average number of patients	1.29 (1.20–1.38)*	1.13 (1.05–1.22)*	1.18 (1.13–1.23)*	1.09 (1.03–1.15)*	1.01 (0.96–1.07)	0.67 (0.52–0.86)	1.30 (1.21–1.40)*	1.21 (1.15–1.28)*	1.21 (1.16–1.27)*	1.11 (1.07–1.16)*	1.06 (1.03–1.10)*

* p < 0.05